期刊
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE
卷 32, 期 2, 页码 78-83出版社
TAYLOR & FRANCIS LTD
DOI: 10.3109/02813432.2014.920597
关键词
Anxiety disorders; Finland; generalized anxiety disorder; general practice; high utilizers of health care; panic disorder; screening
资金
- Northern Finland health care support foundation
- Astra Zeneca
- Oy Bristol-Myers Squibb (Finland) Ab
- Eli Lilly
- Pfizer Oy
- Servier Finland Oy
- H. Lundbeck A/S
To analyse the prevalence of GAD and other anxiety disorders, as well as sensitivity and specificity of GAD-7 among high utilizers of health care. Setting. Four municipal health centres in Northern Finland. Subjects. A psychiatric interview was conducted for 150 high utilizers of health care. Main outcome measures. Prevalence of GAD as well as sensitivity and specifi city of GAD-7. Results. The prevalence of GAD was 4% in this study group of Finnish high utilizers of health care. The sensitivity of GAD-7 was 100.0% (95% CI 54.1-100.0) and the specifi city of GAD-7 was 82.6% (95% CI 75.4 -88.4) with a cut-off point of 7 or more. Conclusion. GAD is rather common among high utilizers of primary care, although the prevalence of 4% is lower than that previously reported. GAD-7 is a valid and useful tool for detecting GAD among primary health care patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据